Greenleaf Trust’s LeMaitre Vascular LMAT Stock Holding History

Greenleaf Trust’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-14,738	Closed	-$363K	–	379
2017 Q1	$363K	Hold	14,738	–	–	0.01%	200
2016 Q4	$373K	Hold	14,738	–	–	0.01%	157
2016 Q3	$292K	Hold	14,738	–	–	0.01%	164
2016 Q2	$210K	Buy	+14,738	New	+$225K	0.01%	169

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Greenleaf Trust's LMAT Position: Q2 2017 in Review

Greenleaf Trust sold out of LeMaitre Vascular (LMAT) in Q2 2017, closing a stake of 14,738 shares — an estimated $363K sold.

Greenleaf Trust first reported a position in LMAT in Q2 2016 and held it in 4 quarters. The position peaked at $373K in Q4 2016. 143 funds tracked by Wall St. Rank hold LMAT as of Q2 2017.

Greenleaf Trust reported no remaining LeMaitre Vascular position as of Q2 2017 after selling out during the quarter.
Greenleaf Trust sold 14,738 LeMaitre Vascular shares in Q2 2017, an estimated $363K.
Greenleaf Trust first reported a position in LeMaitre Vascular in Q2 2016 and held it in 4 quarters.
Greenleaf Trust's LeMaitre Vascular position peaked at $373K in Q4 2016.
143 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2017.

Based on Greenleaf Trust's 13F filing for Q2 2017, filed 24 Jul 2017.